Hair Loss Medications:
Finasteride, Minoxidil
& Dutasteride Guide

Medical Treatment for Hair Loss — The Evidence

While hair transplant surgery is the only permanent solution that physically restores lost hair, medical treatment is the essential first line of management for androgenetic alopecia — and a critical long-term companion to any surgical procedure. The right medications can halt hair loss progression, partially restore lost density in early to moderate stages, and preserve existing hair alongside a transplant for the best long-term outcome.

At Sapphire Roots, Dr. Ashwini takes a rigorous, evidence-based approach to prescribing hair loss medications — based on your specific hair loss type, stage, gender, medical history, and goals. Self-prescribing without medical supervision is inadvisable — the right medication, dose, and combination requires individual assessment.

1. Finasteride — The Gold Standard for Men

Finasteride (brand names: Propecia, Finpecia, Finast) is the most important and most studied oral medication for male androgenetic alopecia. It is a type II 5-alpha reductase inhibitor that reduces the conversion of testosterone to DHT — the hormone responsible for follicle miniaturisation in genetically susceptible men.

How it Works

By inhibiting the type II isoform of 5-alpha reductase, finasteride reduces serum DHT levels by approximately 65–70% and scalp DHT by approximately 60–70%. This dramatically reduces the DHT-mediated miniaturisation of susceptible follicles, halting or slowing progression of androgenetic alopecia.

Effectiveness

• Halts hair loss progression in approximately 85–90% of men
• Produces visible regrowth in approximately 65% of men after 12–24 months of use
• Most effective at the crown (vertex) — the area with highest DHT receptor density
• Benefits begin at 3–6 months and continue accumulating through 12–24 months of use

Dosing

Standard dose: 1mg once daily. Alternative weekly regimens (5mg twice weekly) are sometimes used; evidence suggests similar DHT reduction with reduced systemic exposure. Must be taken long-term — benefits reverse within 12–24 months of stopping.

Side Effects

Finasteride is generally very well-tolerated. Reported side effects (in clinical trials, affecting a small minority):

• Sexual side effects (1–2% in clinical trials): Decreased libido, erectile dysfunction, reduced ejaculate volume. In the vast majority of cases, these resolve upon stopping medication. Post-finasteride syndrome — persistent sexual side effects after stopping — is reported but remains a subject of scientific debate regarding true incidence and causation.
• Breast tenderness/enlargement (rare): Gynaecomastia is an uncommon side effect that resolves upon stopping the medication.
• PSA lowering: Finasteride reduces PSA (prostate-specific antigen) levels by approximately 50% — important for men over 50 undergoing prostate cancer screening. Always inform your urologist if you are taking finasteride.
• NOT for use in women of childbearing potential: Finasteride is teratogenic (causes birth defects in male foetuses). Pre-menopausal women should not use or handle crushed finasteride tablets. Post-menopausal women may use it off-label under medical supervision.

2. Minoxidil — Effective for Both Sexes

Minoxidil (brand names: Rogaine, Mintop, Tugain) is the most widely used topical treatment for hair loss — and the only medication approved by the FDA for female androgenetic alopecia (FPHL). Available as a topical solution or foam (2–5%) and, increasingly, as oral low-dose tablets (0.25–5mg).

How it Works

Minoxidil is a potassium channel opener and vasodilator. Its hair growth mechanism involves: opening potassium channels in dermal papilla cells, prolonging the anagen (growth) phase, increasing follicle size (reversing some miniaturisation), and improving blood flow to the scalp. It does not affect DHT and works independently of the androgen pathway — making it effective in both men and women.

Effectiveness

• Halts progression and reduces shedding in the majority of users
• Visible regrowth in approximately 40–60% of consistent users at 12 months
• Effective in both men and women at all stages of androgenetic alopecia
• Benefits begin at 2–4 months of use
• Initial "shedding" phase in weeks 2–6 of starting minoxidil is normal — indicates the drug is working by pushing hairs into a new growth cycle

Topical vs Oral Minoxidil

• Topical (5% solution or foam): Applied twice daily directly to the scalp. Can cause scalp irritation or hypertrichosis (facial hair growth in women) at higher concentrations. Traditional first-line option.
• Oral low-dose minoxidil (0.5–5mg daily): Rapidly gaining preference — superior convenience (once daily tablet), superior systemic bioavailability, and emerging evidence of superior efficacy compared to topical. Used at doses well below the antihypertensive dose — minimal cardiovascular effects in healthy individuals. Side effects: fluid retention (uncommon at low doses), body/facial hair growth. Currently used off-label for hair loss.

Side Effects

• Topical: scalp irritation, contact dermatitis (often from propylene glycol carrier), unwanted facial hair growth (women)
• Oral: hypertrichosis (body/facial hair growth), mild fluid retention, palpitations (rare at low doses). Contraindicated in significant heart disease, low blood pressure.

3. Dutasteride — The Powerful Alternative

Dutasteride (brand name: Avodart) is a dual 5-alpha reductase inhibitor — inhibiting both type I and type II isoforms of the enzyme, versus finasteride which inhibits only type II. This dual inhibition reduces DHT by up to 90% (vs 65–70% for finasteride) — making it a more potent option for men who have not responded adequately to finasteride, or who need more aggressive DHT suppression.

• Used off-label for hair loss (approved for benign prostatic hyperplasia)
• Standard dose: 0.5mg daily (same as BPH dose)
• Significantly more potent than finasteride — can rescue cases where finasteride was insufficient
• Similar side effect profile to finasteride, potentially slightly higher incidence due to deeper DHT suppression
• Contraindicated in women of childbearing potential (same teratogenic concern as finasteride)

Combination Therapy — The Most Effective Approach

The most effective medical approach to androgenetic alopecia uses multiple treatments simultaneously — addressing different mechanisms for synergistic benefit:

• Finasteride + Minoxidil (standard combination for men): The most commonly prescribed combination. Finasteride addresses the root cause (DHT); minoxidil provides independent growth stimulation. Shown to be significantly superior to either medication alone.
• Minoxidil + Spironolactone (for women): Minoxidil for growth stimulation + spironolactone (anti-androgen) for DHT receptor blockade. The standard female medical combination.
• Triple therapy (Finasteride + Minoxidil + PRP/GFC): Adding biological growth factor stimulation to the medical backbone — the most aggressive non-surgical protocol, producing superior results to medication alone.

Frequently Asked Questions